In the remaining 20% of cases, MTC arises in individuals with multiple endocrine neoplasia syndrome (MEN, types 2 A and 2B) characterized by the presence of a germline mutation of the RET proto-oncogene with autosomal dominant inheritance [118–129]. Here, RET is linked to multiple endocrine neoplasia.